Travel vaccination for rabies

Expert Review of Vaccines

Volumn 7, Issue 5, 2008, Pages 613-620

  Blanton, Jesse D ^a   Rupprecht, Charles E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Rabies; Travel medicine; Vaccination; Zoonosis

Indexed keywords

DIPLOID CELL VACCINE; RABIES IMMUNOGLOBULIN; RABIES VACCINE;

DRUG HYPERSENSITIVITY; HUMAN; INFECTION PREVENTION; INFECTION RISK; PRIORITY JOURNAL; RABIES; RABIES VIRUS; REVIEW; TRAVEL; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT; VACCINATION;

ANIMALS; RABIES; RABIES VACCINES; TRAVEL; VACCINATION;

EID: 45849129411     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.7.5.613     Document Type: Review

References (49)

1. Hemachudha T, Wacharapluesadee S, Mitrabhakdi E et al. Pathophysiology of human paralytic rabies. J. Neurovirol. 11(1), 93-100 (2005).
2. Srinivasan A, Burton EC, Kuehnert MJ et al. Transmission of rabies virus from an organ donor to four transplant recipients. N. Engl. J. Med. 352(11), 1103-1111 (2005).
3. Hellenbrand W, Meyer C, Rasch G, Steffens I, Ammon A. Cases of rabies in Germany following organ transplantation. Euro Surveill. 10(2), E050224-050226 (2005).
4. Houff SA, Burton RC, Wilson RW et al. Human-to-human transmission of rabies virus by corneal transplant. N. Engl. J. Med. 300(11), 603-604 (1979).
5. Briggs DJ. Human rabies vaccines. In: Rabies. Jackson AC, Wunner WH (Eds.) Academic Press, London, UK 505-515 (2007).
6. Baer GM. The history of rabies. In: Rabies. Jackson AC, Wunner WH (Eds.) Academic Press, London, UK 1-22 (2007).
7. US CDC. Human rabies prevention - United States, 1999. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 48(RR-1), 1-21 (1999).
8. Nadin-Davis SA. Molecular epidemiology. In: Rabies. Jackson AC, Wunner WH (Eds.) Academic Press, London, UK 69-115 (2007).
9. Lumlertdacha B, Boongird K, Wanghongsa S et al. Survey for bat lyssaviruses, Thailand. Emerg. Infect. Dis. 11(2), 232-236 (2005).
10. Kuzmin IV, Niezgoda M, Franka R et al. Lagos bat virus in Kenya. J. Clin. Microbiol. 46(4), 1451-1461 (2008).
11. Hanlon CA, Kuzmin IV, Blanton JD et al. Efficacy of rabies biologics against new lyssaviruses from Eurasia. Virus Res. 111(1), 44-54 (2005).
12. Rupprecht CE, Willoughby R, Slate D. Current and future trends in the prevention, treatment and control of rabies. Expert Rev. Anti Infect. Ther. 4(6), 1021-1038 (2006).
13. Blanton JD, Hanlon CA, Rupprecht CE. Rabies surveillance in the United States during 2006. J. Am. Vet. Med. Assoc. 231(4), 540-556 (2007).
14. Kuzmin I, Rupprecht C. Bat rabies. In: Rabies. Jackson AC, Wunner WH (Eds.) Academic Press, London, UK 259-307 (2007).
15. Tamashiro H, Matibag GC, Ditangco RA, Kanda K, Ohbayashi Y. Revisiting rabies Japan: is there cause for alarm? Travel Med. Infect. Dis. 5(5), 263-275 (2007).
16. Identification of a rabid dog in France illegally introduced from Morocco. Euro Surveill. 13(11) 8066 (2008).
17. WHO. WHO Expert consultation on rabies. First report. In: WHO Technical Report Series No 931. WHO, Geneva, Switzerland 121 (2004).
18. Aubert MF. Costs and benefits of rabies control in wildlife in France. Rev. Sci. Tech. 18(2), 533-543 (1999).
19. Meslin F-X, Kaplan MM. General considerations in the production and use brain-tissue and purified chicken-embryo rabies vaccines for human use. In: Laboratory Techniques in Rabies. Meslin F-X, Kaplan MM, Koprowski H (Eds) WHO, Geneva, Switzerland 204-212 (1996).
20. WHO. Recommendations for inactivated rabies vaccine for human use produced in cell substrates and embryonated eggs. In: WHO Technical Report Series, No 941. WHO, Geneva, Switzerland 50 (2007).
21. Plotkin SA, Koprowski H, Rupprecht CE. Rabies vaccines. In: Vaccines. Plotkin SA, Orenstein W, Offit P (Eds) Elsevier, London, UK 687-714 (2008).
22. Mahendra BJ, Madhusudana SN, Ashwathnarayana DH et al. A comparative study on the immunogenicity, safety and tolerance of purified duck embryo vaccine (PDEV) manufactured in India (Vaxirab) and Switzerland (Lyssavac-N): a randomized simulated post-exposure study in healthy volunteers. Vaccine 25(50), 8405-8409 (2007).
23. Khawplod P, Glueck R, Wilde H et al. Immunogenicity of purified duck embryo rabies vaccine (Lyssavac-N) with use of the WHO-approved intradermal postexposure regimen. Clin. Infect. Dis. 20(3), 646-651 (1995).
24. Wilde H, Chutivongse S. Equine rabies immune globulin: a product with an undeserved poor reputation. Am. J. Trop. Med. Hyg. 42(2), 175-178 (1990).
25. CDC. Diphtheria, tetanus, and pertussis: recommendations for vaccine use and other preventive measures. Recommendations of the Immunization Practices Advisory committee (ACIP). MMWR Recomm. Rep. 40(RR-10), 1-28 (1991).
26. Wilde H, Tipkong P, Khawplod P. Economic issues in postexposure rabies treatment. J. Travel Med. 6(4), 238-242 (1999).
27. Phanuphak P, Khawplod P, Sirivichayakul S et al. Humoral and cell-mediated immune responses to various economical regimens of purified Vero cell rabies vaccine. Asian Pac. J. Allergy Immunol. 5(1), 33-37 (1987).
28. Warrell MJ, Riddell A, Yu LM et al. A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods. PLoS Negl. Trop. Dis. 2(4), e224 (2008).
29. Noah DL, Drenzek CL, Smith JS et al. Epidemiology of human rabies in the United States, 1980 to 1996. Ann. Intern. Med. 128(11), 922-930 (1998).
30. Human rabies - New Hampshire, 1996. MMWR Morb. Mortal. Wkly Rep. 46(12), 267-270 (1997).
31. US CDC. CDC Health Information for International Travel 2008. US Department of Health and Human Services, Public Health Service, GA, USA (2007).
32. LeGuerrier P, Pilon PA, Deshaies D, Allard R. Pre-exposure rabies prophylaxis for the international traveller: a decision analysis. Vaccine 14(2), 167-176 (1996).
33. Bernard KW, Fishbein DB. Pre-exposure rabies prophylaxis for travellers: are the benefits worth the cost? Vaccine 9(11), 833-836 (1991).
34. Pancharoen C, Thisyakorn U, Tantawichien T et al. Failure of pre- and postexposure rabies vaccinations in a child infected with HIV. Scand. J. Infect. Dis. 33(5), 390-391 (2001).
35. Tantawichien T, Jaijaroensup W, Khawplod P, Sitprija V. Failure of multiple-site intradermal postexposure rabies vaccination in patients with human immunodeficiency virus with low CD4+ T lymphocyte counts. Clin. Infect. Dis. 33(10), E122-E124 (2001).
36. Hay E, Derazon H, Bukish N, Scharf S, Rishpon S. Postexposure rabies prophylaxis in a patient with lymphoma. JAMA 285(2), 166-167 (2001).
37. Blanton JD, Bowden NY, Eidson M, Wyatt JD, Hanlon CA. Rabies postexposure prophylaxis, New York, 1995-2000. Emerg. Infect. Dis. 11(12), 1921-1927 (2005).
38. Willoughby RE Jr, Tieves KS, Hoffman GM et al. Survival after treatment of rabies with induction of coma. N. Engl. J. Med. 352(24), 2508-2514 (2005).
39. Briggs D, Hanlon CA. World Rabies Day: focusing attention on a neglected disease. Vet. Rec. 161(9), 288-289 (2007).
40. Dedmon R. Mad dogs and Englishmen. Asian Biomedicine 2(1), 1-8 (2008).
41. Sugiyama M, Ito N. Control of rabies: epidemiology of rabies in Asia and development of new-generation vaccines for rabies. Comp. Immunol. Microbiol. Infect. Dis. 30(5-6), 273-286 (2007).
42. Schneider MC, Belotto A, Ade MP et al. Current status of human rabies transmitted by dogs in Latin America. Cad Saude Publica 23(9), 2049-2063 (2007).
43. Costa WA, Cunha RS, Bolzan VL et al. Immunogenicity and safety of a new Vero cell rabies vaccine produced using serumfree medium. Vaccine 25(48), 8140-8145 (2007).
44. Kulkarni PS, Raut SK, Jadhav SS, Kapre SV, Deuskar N. Immunogenicity of two modern tissue culture rabies vaccines in pre-exposure prophylaxis. Hum. Vaccin. 3(5), 183-186 (2007).
45. Ambrozaitis A, Laiskonis A, Balciuniene L, Banzhoff A, Malerczyk C. Rabies postexposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen. Vaccine 24(19), 4116-4121 (2006).
46. Parkinson AJ, Butler JC. Potential impacts of climate change on infectious diseases in the Arctic. Int. J. Circumpolar Health 64(5), 478-486 (2005).
47. Welbergen JA, Klose SM, Markus N, Eby P. Climate change and the effects of temperature extremes on Australian flyingfoxes. Proc. Biol. Sci. 275(1633), 419-425 (2008).
48. Tordo N, Bahloul C, Jacob Y et al. Rabies: epidemiological tendencies and control tools. Dev. Biol. (Basel) 125, 3-13 (2006).
49. CDC. About rabies www.cdc.gov/rabies/about.html